Comparison of drug permeabilities and BCS classification: three lipid-component PAMPA system method versus Caco-2 monolayers.
作者信息
Teksin Zeynep S, Seo Paul R, Polli James E
机构信息
University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA.
出版信息
AAPS J. 2010 Jun;12(2):238-41. doi: 10.1208/s12248-010-9176-2. Epub 2010 Mar 12.
Abstract
摘要
相似文献
1
Comparison of drug permeabilities and BCS classification: three lipid-component PAMPA system method versus Caco-2 monolayers.药物渗透性与生物药剂学分类系统的比较：三种脂质成分的平行人工膜渗透法与Caco-2单层细胞法
AAPS J. 2010 Jun;12(2):238-41. doi: 10.1208/s12248-010-9176-2. Epub 2010 Mar 12.
2
Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery.平行人工膜通透性测定和Caco-2通透性测定在药物研发中的联合应用。
J Pharm Sci. 2004 Jun;93(6):1440-53. doi: 10.1002/jps.20075.
3
Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.评价各种 PAMPA 模型，以确定最具区分度的方法来预测 BBB 通透性。
Eur J Pharm Biopharm. 2010 Mar;74(3):495-502. doi: 10.1016/j.ejpb.2010.01.003. Epub 2010 Jan 11.
4
Caco-2 permeability of weakly basic drugs predicted with the double-sink PAMPA pKa(flux) method.采用双池PAMPA pKa（通量）法预测弱碱性药物的Caco-2通透性。
Eur J Pharm Sci. 2005 Mar;24(4):333-49. doi: 10.1016/j.ejps.2004.11.011. Epub 2005 Jan 20.
5
Ion pair-mediated transport of metoprolol across a three lipid-component PAMPA system.离子对介导的美托洛尔跨三脂质成分的平行人工膜渗透系统的转运。
J Control Release. 2006 Nov;116(1):50-7. doi: 10.1016/j.jconrel.2006.08.020. Epub 2006 Sep 6.
6
The permeation of amphoteric drugs through artificial membranes--an in combo absorption model based on paracellular and transmembrane permeability.两性药物透过人工膜的渗透作用——基于细胞旁和跨膜通透性的组合吸收模型。
J Med Chem. 2010 Jan 14;53(1):392-401. doi: 10.1021/jm901421c.
7
Biopharmaceutics classification by high throughput solubility assay and PAMPA.通过高通量溶解度测定和平行人工膜渗透试验进行生物药剂学分类
Drug Dev Ind Pharm. 2004 Feb;30(2):181-5. doi: 10.1081/ddc-120028713.
8
Relationships between structure and high-throughput screening permeability of peptide derivatives and related compounds with artificial membranes: application to prediction of Caco-2 cell permeability.肽衍生物及相关化合物与人工膜的结构和高通量筛选通透性之间的关系：在预测Caco-2细胞通透性中的应用
Bioorg Med Chem. 2004 Jan 2;12(1):257-64. doi: 10.1016/j.bmc.2003.10.002.
9
The suitability of an in situ perfusion model for permeability determinations: utility for BCS class I biowaiver requests.用于渗透性测定的原位灌注模型的适用性：对BCS I类生物豁免申请的效用
Mol Pharm. 2006 Nov-Dec;3(6):686-94. doi: 10.1021/mp060042f.
10
Parallel artificial membrane permeability assay (PAMPA) - Is it better than Caco-2 for human passive permeability prediction?平行人工膜透过性测定法（PAMPA）- 其用于预测人体被动通透性是否优于 Caco-2 细胞？
Mini Rev Med Chem. 2010 Oct;10(11):1071-6. doi: 10.2174/1389557511009011071.
引用本文的文献
1
Development of analytical functions with high-performance liquid phase separation systems on the basis of the moment theory.基于矩理论的高效液相分离系统分析函数的开发。
Anal Sci. 2025 Aug;41(8):1269-1287. doi: 10.1007/s44211-025-00821-w. Epub 2025 Jul 7.
2
Discovery of a Novel [6-6-5-5-6] Pentacyclic Tetrahydrocyclopentaphthalazinone as a Promising PARP Inhibitor Scaffold.发现一种新型[6-6-5-5-6]五环四氢环戊并酞嗪酮作为一种有前景的聚（ADP-核糖）聚合酶（PARP）抑制剂骨架。
ACS Med Chem Lett. 2025 Apr 3;16(5):776-783. doi: 10.1021/acsmedchemlett.4c00603. eCollection 2025 May 8.
3
Quantitative in vitro-to-in vivo extrapolation of human adrenergic and trace amine-associated receptor 1 potencies of pre-workout supplement ingredients using physiologically based kinetic modelling-based reverse dosimetry.使用基于生理药代动力学模型的反向剂量测定法对运动前补充剂成分的人肾上腺素能和痕量胺相关受体1效价进行体外到体内的定量外推。
Arch Toxicol. 2025 May;99(5):1999-2021. doi: 10.1007/s00204-025-03992-7. Epub 2025 Apr 3.
4
Prodrug Approach as a Strategy to Enhance Drug Permeability.前药策略作为增强药物渗透性的一种方法。
Pharmaceuticals (Basel). 2025 Feb 21;18(3):297. doi: 10.3390/ph18030297.
5
Meta-Analysis of Permeability Literature Data Shows Possibilities and Limitations of Popular Methods.渗透率文献数据的Meta分析显示了常用方法的可能性和局限性。
Mol Pharm. 2025 Mar 3;22(3):1293-1304. doi: 10.1021/acs.molpharmaceut.4c00975. Epub 2025 Feb 20.
6
Comparative analysis of Caco-2 cells and human jejunal and duodenal enteroid-derived cells in gel- and membrane-based barrier models of intestinal permeability.在基于凝胶和膜的肠道通透性屏障模型中对Caco-2细胞与源自人空肠和十二指肠的肠上皮细胞进行比较分析。
Toxicol Sci. 2025 Apr 1;204(2):181-197. doi: 10.1093/toxsci/kfaf011.
7
Bioengineering the Human Intestinal Mucosa and the Importance of Stromal Support for Pharmacological Evaluation In Vitro.生物工程化的人肠道黏膜及其在体外药物评价中基质支持的重要性。
Cells. 2024 Nov 8;13(22):1859. doi: 10.3390/cells13221859.
8
Screening oral drugs for their interactions with the intestinal transportome via porcine tissue explants and machine learning.通过猪组织外植体和机器学习筛选与肠道转运体相互作用的口服药物。
Nat Biomed Eng. 2024 Mar;8(3):278-290. doi: 10.1038/s41551-023-01128-9. Epub 2024 Feb 20.
9
Canine Intestinal Organoids as a Novel In Vitro Model of Intestinal Drug Permeability: A Proof-of-Concept Study.犬肠道类器官作为一种新型的肠道药物渗透体外模型：概念验证研究。
Cells. 2023 Apr 27;12(9):1269. doi: 10.3390/cells12091269.
10
Reliable Prediction of Caco-2 Permeability by Supervised Recursive Machine Learning Approaches.通过监督递归机器学习方法对Caco-2细胞通透性进行可靠预测。
Pharmaceutics. 2022 Sep 21;14(10):1998. doi: 10.3390/pharmaceutics14101998.
本文引用的文献
1
Transport evaluation of salicylic acid and structurally related compounds across Caco-2 cell monolayers and artificial PAMPA membranes.水杨酸及结构相关化合物跨Caco-2细胞单层和人工PAMPA膜的转运评估。
Eur J Pharm Biopharm. 2008 Oct;70(2):531-8. doi: 10.1016/j.ejpb.2008.05.017. Epub 2008 Jun 6.
2
3
Predicting human intestinal permeability using single-pass intestinal perfusion in rat.利用大鼠单通道肠道灌注预测人体肠道通透性
J Pharm Pharm Sci. 2007;10(3):368-79.
4
Ion pair-mediated transport of metoprolol across a three lipid-component PAMPA system.离子对介导的美托洛尔跨三脂质成分的平行人工膜渗透系统的转运。
J Control Release. 2006 Nov;116(1):50-7. doi: 10.1016/j.jconrel.2006.08.020. Epub 2006 Sep 6.
5
Lipid composition effect on permeability across PAMPA.脂质组成对跨人工膜磷脂双分子层通透性的影响。
Eur J Pharm Sci. 2006 Nov;29(3-4):259-68. doi: 10.1016/j.ejps.2006.04.012. Epub 2006 May 4.
6
Current industrial practices of assessing permeability and P-glycoprotein interaction.评估通透性和P-糖蛋白相互作用的当前工业实践。
AAPS J. 2006 Jan 13;8(1):E1-13. doi: 10.1208/aapsj080101.
7
Development and evaluation of an in vitro method for prediction of human drug absorption II. Demonstration of the method suitability.用于预测人体药物吸收的体外方法的开发与评估II. 方法适用性的验证
Eur J Pharm Sci. 2006 Mar;27(4):354-62. doi: 10.1016/j.ejps.2005.11.005. Epub 2005 Dec 20.
8
Relationships between structure and high-throughput screening permeability of diverse drugs with artificial membranes: application to prediction of Caco-2 cell permeability.不同药物与人工膜的结构和高通量筛选通透性之间的关系：在预测Caco-2细胞通透性中的应用
Bioorg Med Chem. 2005 Aug 1;13(15):4721-32. doi: 10.1016/j.bmc.2005.04.076.
9
Caco-2 permeability of weakly basic drugs predicted with the double-sink PAMPA pKa(flux) method.采用双池PAMPA pKa（通量）法预测弱碱性药物的Caco-2通透性。
Eur J Pharm Sci. 2005 Mar;24(4):333-49. doi: 10.1016/j.ejps.2004.11.011. Epub 2005 Jan 20.
10
Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: verapamil hydrochloride, propranolol hydrochloride, and atenolol.基于生物药剂学分类系统（BCS）文献数据的速释固体口服制剂生物豁免专论：盐酸维拉帕米、盐酸普萘洛尔和阿替洛尔。
J Pharm Sci. 2004 Aug;93(8):1945-56. doi: 10.1002/jps.20131.
Zotero 插件